clindamycin has been researched along with Staphylococcal Pneumonia in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (21.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
Duployez, C; Le Guern, R; Lejeune, AL; Loïez, C; Robriquet, L; Six, S; Tinez, C; Wallet, F | 1 |
Ferry, T; Perpoint, T; Roux, S; Vandenesch, F | 1 |
Tibebu, M | 1 |
Abu Ghanimeh, M; Abu Omar, M; Gohar, A; Tylski, E | 1 |
Barcelo, M; Boukhari, R; Chauvet, E; Mbieleu, B | 1 |
Blumberg, HM; Hidron, AI; Honig, EG; Low, CE | 1 |
Lobo, LJ; Reed, KD; Wunderink, RG | 1 |
Carrillo-Marquez, MA; Hammerman, W; Hulten, KG; Kaplan, SL; Lamberth, L; Mason, EO | 1 |
Diaz, E; Fernandez, IM; Jimenez, L; Rodriguez, M; Surani, S | 1 |
Falagas, ME; Michalopoulos, A | 1 |
Griffin, E; Mulhern, B | 1 |
Fateeva, LI; Poliak, MS | 1 |
Alfidi, RJ; Braun, WE; Deodhar, SD; McHenry, MC; Popowniak, KL | 1 |
1 review(s) available for clindamycin and Staphylococcal Pneumonia
Article | Year |
---|---|
Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clindamycin; Communicable Diseases, Emerging; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Exotoxins; Female; Genotype; Humans; Intubation, Intratracheal; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillin-Binding Proteins; Pneumonia, Staphylococcal; United States; Virulence Factors | 2009 |
13 other study(ies) available for clindamycin and Staphylococcal Pneumonia
Article | Year |
---|---|
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.
Topics: Adult; Anti-Bacterial Agents; Bacterial Toxins; Betacoronavirus; Cefotaxime; Clindamycin; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Exotoxins; Fatal Outcome; Humans; Leukocidins; Linezolid; Male; Metronidazole; Necrosis; Pandemics; Pneumonia, Staphylococcal; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Spiramycin; Staphylococcus aureus; Tomography, X-Ray Computed | 2020 |
Necrotising pneumonia following influenza due to PVL-negative
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Exotoxins; Female; Gentamicins; Humans; Immunocompetence; Influenza, Human; Leukocidins; Lung; Middle Aged; Oxacillin; Pneumonia, Necrotizing; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed | 2017 |
Severe hospital acquired pneumonia and septicemia due TO methicillin resistant Staphylococcus lugdunensis in a newborn in Northwestern Ethiopia.
Topics: Anti-Bacterial Agents; Clindamycin; Cross Infection; Erythromycin; Humans; Infant; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Sepsis; Staphylococcus lugdunensis; Treatment Outcome | 2014 |
Congenital pulmonary airway malformation (CPAM) with initial presentation in an adult: a rare presentation of a rare disease.
Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoscopy; Clindamycin; Cystic Adenomatoid Malformation of Lung, Congenital; Drug Substitution; Humans; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2016 |
[Staphylococcic necrotizing pneumopathy due to Panton-Valentine leukocidin toxin with good outcome].
Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Toxins; Clindamycin; Drug Therapy, Combination; Exotoxins; Follow-Up Studies; Humans; Leukocidins; Male; Methylprednisolone; Oxacillin; Pneumonia, Staphylococcal; Pristinamycin; Radiography, Thoracic; Risk Factors; Staphylococcus aureus; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Follow-Up Studies; Humans; Illinois; Incidence; Linezolid; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Prognosis; Retrospective Studies; RNA, Ribosomal, 23S; Survival Rate; Time Factors; Young Adult | 2010 |
Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Comorbidity; Electrophoresis, Gel, Pulsed-Field; Exotoxins; Female; Hospitals; Humans; Incidence; Infant; Infant, Newborn; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Molecular Typing; Pneumonia, Staphylococcal; Polymerase Chain Reaction; Texas; Treatment Outcome; Virulence Factors; Virus Diseases; Young Adult | 2011 |
Is methicillin-resistant Staphylococcus aureus pneumonia epidemiology and sensitivity changing?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clindamycin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Multi-systemic methicillin resistant Staphylococcus aureus (MRSA) community-acquired infection.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Linezolid; Low Back Pain; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Spinal Diseases; Staphylococcus aureus | 2006 |
An epidemic oc gentamicin/cloxacillin resistant staphylococcal infection in a neonatal unit.
Topics: Amikacin; Clindamycin; Cloxacillin; Cross Infection; Female; Gentamicins; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Kanamycin; Male; Pneumonia, Staphylococcal; R Factors; Staphylococcal Infections; Staphylococcus aureus | 1981 |
[Effectiveness of the inhalatory administration of chlolincocin in experimental staphylococcal pneumonia].
Topics: Animals; Biological Availability; Clindamycin; Drug Evaluation, Preclinical; Injections, Intravenous; Lincomycin; Lung; Mice; Mice, Inbred Strains; Pneumonia, Staphylococcal; Respiratory Therapy; Staphylococcus aureus | 1976 |
Hospital-acquired pneumonia.
Topics: Adolescent; Ampicillin; Aspergillus; Bacteria; Bacteroides; Candida; Carbenicillin; Clindamycin; Cross Infection; Enterobacteriaceae; Female; Gentamicins; Humans; Immunosuppression Therapy; Klebsiella pneumoniae; Male; Penicillin G; Pneumonia; Pneumonia, Staphylococcal; Pneumonia, Viral; Proteus; Pseudomonas; Radiography | 1974 |